| | |||||
| lung cancer | |||||
| 新闻 | |||||
| Atebimetinib Combo Shows Compelling 1-Year OS in First-Line Pancreatic Cancer Other cancer types investigated include non–small cell lung cancer and malignant cutaneous melanoma. Participants in the frontline PDAC cohort ...
| |||||
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment